ym 12617 has been researched along with Adenoma, Prostatic in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aso, Y; Kato, H; Kawabe, K; Takimoto, Y; Ueno, A | 1 |
| Ashizawa, N; Hayashi, E; Honda, K; Nakayama, K; Ushijima, H; Yamada, S | 1 |
| Kawabe, K; Niijima, T | 1 |
2 trial(s) available for ym 12617 and Adenoma, Prostatic
| Article | Year |
|---|---|
Use of an alpha 1-blocker, YM617, in the treatment of benign prostatic hypertrophy. YM617 Clinical Study Group.
Topics: Adrenergic alpha-Antagonists; Aged; Aged, 80 and over; Double-Blind Method; Humans; Male; Middle Aged; Multicenter Studies as Topic; Prostatic Hyperplasia; Random Allocation; Sulfonamides; Urodynamics | 1990 |
Use of an alpha 1-blocker, YM-12617, in micturition difficulty.
Topics: Adrenergic alpha-Antagonists; Clinical Trials as Topic; Drug Evaluation; Female; Humans; Male; Middle Aged; Prospective Studies; Prostatic Hyperplasia; Sulfonamides; Urination Disorders | 1987 |
1 other study(ies) available for ym 12617 and Adenoma, Prostatic
| Article | Year |
|---|---|
Alpha-1 adrenoceptors in human prostate: characterization and alteration in benign prostatic hypertrophy.
Topics: Binding, Competitive; Humans; Male; Prazosin; Prostate; Prostatic Hyperplasia; Receptors, Adrenergic, alpha; Sulfonamides | 1987 |